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Abstract
Nod2 is a cytosolic pattern recognition receptor. It has been implicated in many inflammatory conditions. Its signaling has
been suggested to modulate TLR responses in a variety of ways, yet little is known about the mechanistic details of the
process. We show in this study that Nod2 knockdown mouse peritoneal macrophages secrete more IL1b than normal
macrophages when stimulated with peptidoglycan (PGN). Muramyl dipeptide (MDP, a Nod2 ligand) + PGN co-stimulated
macrophages have lower expression of IL1b than PGN (TLR2/1 ligand) stimulated macrophages. MDP co-stimulation have
similar effects on Pam3CSK4 (synthetic TLR2/1 ligand) mediated IL1b expression suggesting that MDP mediated down
regulating effects are receptor dependent and ligand independent. MDP mediated down regulation was specific for TLR2/1
signaling as MDP does not affect LPS (TLR4 ligand) or zymosan A (TLR2/6 ligand) mediated IL1b expression. Mechanistically,
MDP exerts its down regulating effects by lowering PGN/Pam3CSK4 mediated nuclear cRel levels. Lower nuclear cRel level
were observed to be because of enhanced transporting back rather than reduced nuclear translocation of cRel in MDP +
PGN stimulated macrophages. These results demonstrate that Nod2 and TLR2/1 signaling pathways are independent and
do not interact at the level of MAPK or NF-kB activation.
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Introduction
TLRs (toll like receptors) are transmembrane pattern recogni-
tion receptors (PRRs) and are among first line of pathogen
recognition molecules. Each TLR is now believed to detect a
discrete collection of molecules of microbial origin (pathogen/
microbe associated molecular patterns, PAMPs/MAMPs) and to
signal the presence of infection. TLRs play central role in
induction of inflammatory and antimicrobial pathways upon
pathogen recognition which ultimately result in immune response
and pathogen clearance [1]. Apart from membrane associated
PRRs there is another class of PRRs which are cytosolic e.g. NOD
(nucleotide binding oligomerization domain) like receptors. Nod1
and Nod2 are most studied representative members of this family
[2]. These molecules are believed to detect peptidoglycan
degradation products (iE-DAP and MDP being the minimal
bioactive motifs respectively) [3,4]. There are various diseases
which show significant association with the mutated forms of
cytosolic PRRs. Crohn’s disease is such a clinically significant
disorder associated with mutant forms of Nod2 [5]. The disease is
characterised by chronic intestinal inflammation. There are
reports that Nod2 modulates the activity of TLR2 which results
in lower Th1 cytokine production after receptor stimulation. In
absence of this modulation (e.g. where patients have mutated
Nod2) macrophages show enhanced TLR2 mediated Th1
responses which help in progression of disease [6]. On the
contrary, there are also reports of synergistic roles of TLRs and
Nod2 [7]. But in above cases and in related studies thereafter
mechanistic details of Nod2 mediated regulation of TLR signaling
are lacking [8]. In this study we asked how Nod2 affects function
of TLRs. Is there any preference for a particular TLR and what
can be the possible mechanism of action?
We used mouse peritoneal macrophages to show that MDP
signaling through Nod2 results in downregulation of PGN (TLR2/
1 ligand) induced IL1b expression. However, it was ineffective in
downregulating zymosan A (TLR2/6 ligand) or LPS (TLR4
ligand) induced IL1b expression. Our results show that modula-
tory effects of MDP are restricted to TLR2/1 ligands only.
Reduced IL1b expression was observed to be due to reduced levels
of cRel in nucleus of MDP + PGN treated macrophages. Reduced
levels of cRel in the nucleus of MDP + PGN co-stimulated
macrophages are observed to be due to enhanced transporting
back from nucleus to cytosol rather than reduced nuclear
translocation of cRel.
Materials and Methods
Ethics Statement
Studies presented in this manuscript were approved by Scrutiny
Committee of School of Biotechnology, Banaras Hindu Univer-
sity, as per University directive no. R/Dev/Project 1987/dt. 31–
11–1987.
Mice
Inbred strains of BALB/c mice of either sex at 8–10 weeks of
age were used for obtaining peritoneal macrophages.
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MDP, Pam3CSK4 were purchased from Invivogen, San Diego,
CA, USA. PGN (S. aureus), ultrapure LPS (E. coli), zymosan A (S.
cerevisiae), cycloheximide and most other reagents were purchased
from Sigma–Aldrich Chemicals, St.Louis, MO, USA. MAPK
inhibitors were purchased from Calbiochem, La Jolla, CA, USA.
TLR2 specific neutralizing antibody (clone: T2.5) was purchased
from eBiosciences, San Diego, CA, USA.
Isolation of macrophages and culture conditions
Macrophages were isolated as described previously [9].
Macrophages were cultured in RPMI 1640 medium (Sigma–
Aldrich Chemicals, St.Louis, MO, USA) supplemented with 10%
fetal calf serum (Biological Industries, Israel), penicillin (100 U/
ml), streptomycin (100 U/ml) and gentamycin (20 mg/ml) in a
humified CO2 incubator. Optimal doses for various stimulants and
pharmacological inhibitors were determined by dose kinetics
experiments.
Real Time RT PCR analysis
Total RNA was isolated from the macrophages by TRI reagent
(Sigma–Aldrich Chemicals, St.Louis, MO, USA) according to
suppliers’ instructions. Real time RT-PCR was done using single
step real time RT-PCR kit (Qiagen, Hilden, Germany) in Bio-Rad
iQ5 real time PCR machine (Bio-Rad Laboratories, Hercules, CA,
USA) using SYBR Green detection protocol. Following gene
specific primers were used for amplifying genes: IL1b Forward
GCAACTGTTCCTGAACTCAACT; Reverse ATCTTTTG-
GGGTCCGTCAACT; GAPDH Forward TGACCACAGTC-
CATGCCATC; Reverse GACGGACACATTGGGGGTAG.
Reverse transcription was performed for 30 minutes at 50uC
then reverse transcriptase was inactivated at 95uC for 15 min.
Amplification was performed with cycling conditions of 94uC for
15 sec, 57uC for 30 sec and 72uC for 30 sec for 35 cycles. After
amplification protocol was over, PCR product was subjected to
melt curve analysis using Bio-Rad iQ5 software. We used the
comparative cycle threshold method (
DDCt method) for relative
quantitation of gene expression [10]. Ct values were calculated
by software automatically after completion of run.
DDCt was
calculated using formula
DDCt~ CtGOI{CtHG ðÞ experimental sample{ CtGOI{CtHG ðÞ control sample
GOI is gene of interest while HG is housekeeping gene.
Fold increase in gene expression was determined using formula
Fold Expression~2{DDCt
Measurement of Cytokine production
Concentration of IL1b in culture supernatants and cell lysates
was measured by enzyme linked immunosorbant assay using BD
OptEIA mouse IL1b ELISA set (BD Biosciences, San Diego, CA,
USA) using protocol provided by manufacturer.
Culture supernatants were directly used for secreted IL1b
quantification.
Western Blot Analysis
The macrophage monolayers were washed with ice-cold
phosphate-buffered saline containing 1 mM Na3VO4, lysed in
lysis buffer [20 mM Tris-HCl pH 8, 137 mM NaCl, 10% glycerol
(v/v), 1% Triton X-100 (v/v), 1 mM Na3VO4, 2 mM EDTA,
1 mM PMSF, working concentration of mammalian protease
inhibitor cocktail] for 10 min at 4uC. The lysates were centrifuged
at 15,000 x g for 15 min and the supernatants were separated on
10% SDS-polyacrylamide gels. The separated proteins (40 mg/
lane) were transferred to a nitrocellulose membrane (1 hour at
350 mA) using a Bio-Rad Mini Transblotter and membrane was
blocked with 5% serum for 2 hours at room temperature and
incubated with primary antibody (Santa Cruz biotechnology,
Santa Cruz, CA, USA) for 1 hour at room temperature and then
with HRP labelled secondary antibody (Santa Cruz biotechnology,
Santa Cruz, CA, USA) for 1 hour at room temperature. The blot
was developed using ECL reagent (Santa Cruz biotechnology
California, USA). To monitor equal loading of protein, western
blot analysis using antibody directed against actin was performed.
Gene knockdown studies
Macrophages were cultured overnight at density of 1x 10
6 cells
per well in 24 well tissue culture plate (Nunc, Roskilde, Denmark).
Pre designed siRNA were used for gene knockdown (Santa Cruz,
USA). Transfection was performed using N-TER Nanoparticle
siRNA Transfection System (Sigma–Aldrich, USA) according
to manufacturer instructions. Final siRNA concentration was
100 nM. Transfection was performed for five hours. After five
hours medium containing siRNA-complex was removed and
replaced by RPMI 1640 supplemented with 10% FCS. Cells were
left undisturbed for 48-72 hours after transfection. One set of cells
was also transfected with negative control scrambled siRNA to rule
out the effects on macrophages because of transfection process.
Gene knockdown was confirmed after 24 hours with real time RT-
PCR and after 48–72 hours with western blot analysis.
Electrophoretic Mobility Shift Assay (EMSA)
Nuclear proteins were isolated using NE-PER Nuclear and
Cytoplasmic Extraction Reagent kit (Thermo scientific, Rockford,
USA). For binding reaction and detection, LightShift Chemilu-
miniscent EMSA and Chemiluminiscent Nucleic Acid Detection
module were used respectively (Thermo scientific, Rockford,
USA). Briefly, 100 fmol of labelled probe was incubated with
nuclear extract (,5 mg proteins) in a total volume of 20 ml for
20 min at room temperature with 16binding buffer. To prevent
non-specific binding of nuclear proteins, 100 ng of poly dI:dC was
added and the specificity of retarded bands was confirmed by
including 1006 excess of unlabelled oligonucleotides. Protein-
DNA complexes were separated from unbound DNA using 6%
native PAGE.
Sequences of probes were as follows: NF-kB probe- 5`-Biotin-
AGTTGAGGGGACTTTCCCAGGC-3`; AP-1 probe- 5`-Biotin-
CGCTTGATGACTCAGCCGGAA-3`.
Statistics
The statistical significance of difference between the test groups
was analysed by ANOVA. P value of less than 0.05 was considered
significant. The deviation bars of the values represent 95%
confidence interval.
Results
Stimulation of peritoneal macrophages with PGN but not
with MDP triggers IL1b release
Stimulation of Nod2 has been reported to trigger release of
cytokine IL1b [11,12]. Patients with mutations in CARD15 that
makes constitutively active Nod2 are found to release enhanced
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stimulation with MDP induces IL1b release by mouse peritoneal
macrophages. Peritoneal macrophages were treated with MDP
(10 mg/ml) or PGN (8 mg/ml). The culture supernatants collected
after different time intervals were assayed for presence of secreted
IL1b. Only PGN was found to trigger release of IL1b (Fig. 1A).
Figure 1. Stimulation of peritoneal macrophages with PGN, but not with MDP, triggers IL1b release. (A-F), (A) Mouse peritoneal
macrophages (1610
6/well/ml) were left untreated or treated with MDP (10 mg/ml) or PGN (8 mg/ml) for indicated time intervals. Culture supernatant
was checked for the presence of IL1b by ELISA. Statistical significance was checked by two way ANOVA. P value was found to be significant (,0.0001).
(B) Macrophages were left untreated or treated with MDP or PGN for 4 hours and cell extracts were analysed for the presence of IL1b using western
blotting. (C) Mouse peritoneal macrophages were left untreated or treated with MDP (10 mg/ml) or PGN (8 mg/ml) for indicated time intervals. Total
RNA was isolated using TRI reagent and was checked for the presence of IL1b transcripts using real time RT-PCR. The bars show fold increase
compared to control macrophages. Statistical significance was checked by two way ANOVA. P value was found to be significant (,0.0001). (D)
Macrophages were left untreated or treated as indicated (time in minutes) and cell extracts were analysed for the presence of phosphorylated forms
of JNK, ERK and p38 using western blotting. (E) Macrophages were pre-treated or left untreated with ERK inhibitor PD98059 (50 mM) for 30 minutes
and then stimulated with MDP for 2 hours. Total RNA was isolated and checked for the presence of IL1b transcripts. The graph shows fold increase in
IL1b transcripts relative to untreated macrophages. Statistical significance was checked by one way ANOVA. P value was found to be significant
(,0.0001). (F) Macrophages were left untreated or treated as indicated (time in minutes) and cell extracts were analysed for the presence of
phosphorylated forms of IkB using western blotting. Blots correspond to one representative experiment of three independent experiments. Results in
graph are presented as the mean of triplicate wells 6 SD.
doi:10.1371/journal.pone.0027828.g001
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was observed that only PGN stimulated macrophages show
enhanced level of pre-IL1b while MDP mediated pre-IL1b level
was not significantly changed compared to control macrophages
(Fig. 1B).
Transcriptional activation of IL1b gene was also checked by
real time RT-PCR. MDP was observed to induce IL1b
transcription. The level of IL1b transcripts was significantly lower
in MDP treated macrophages as compared to PGN stimulated
macrophages (Fig. 1C). To study the molecular mechanism
involved in the transcription/expression of IL1b after MDP and
PGN stimulation, role of MAPKs was investigated. Only ERK was
observed to be activated upon MDP stimulation in peritoneal
macrophages while PGN was able to activate p38, JNK and ERK
MAPKs (Fig. 1D).
To investigate the role of ERK in MDP mediated IL1b
transcription, macrophages were pre-incubated with ERK inhibitor
PD98059 (50 mM) for 30 minutes and then stimulated with MDP
for 2 hours. Total mRNA was checked for the presence of IL1b
transcripts using real time RT-PCR. PD98059 significantly
inhibited the MDP mediated transcription of IL1b (Fig. 1E). There
are reports of MDP mediated activation of NF-kB [3,14,15].
Therefore, MDP mediated NF-kB activation in peritoneal
macrophages was investigated. MDP was observed to be a weak
stimulant for phosphorylation of IkB as compared to PGN (Fig. 1F).
PGN mediated IL1b production is through TLR2 and
involves NF-kB and JNK pathways
PGN stimulation of macrophages caused transcription and
secretion of IL1b. There are contradictory reports on the
involvement of TLR2 as receptor for PGN [16]. Therefore, the
role of TLR2 in PGN mediated IL1b expression was investigated.
Normal or TLR2 knockdown/TLR2 blocking antibody pre-
treated peritoneal macrophages were stimulated with PGN. After
12 hours of stimulation culture supernatants were collected and
checked for the presence of IL1b. Level of secreted IL1b was
found to be significantly lower in TLR2 knockdown/TLR2
blocking antibody pre-treated macrophages as compared to
normal macrophages (Fig. 2A). At transcriptional level also similar
effects were observed when TLR2 knockdown/TLR2 blocking
antibody treated macrophages and normal macrophages were
stimulated with PGN for 2 hours and their total RNA was
analysed for the presence of IL1b transcripts using real time RT-
PCR (Fig. 2B). These observations support the role of TLR2 as
PGN receptor.
Involvement of NF-kB in the expression of IL1b has been
reported [17]. Therefore, role of NF-kB in PGN mediated IL1b
expression in peritoneal macrophages was studied. cRel (a subunit
of NF-kB) knockdown macrophages and normal macrophages
were stimulated with PGN. Culture supernatants were collected
after 12 hours and checked for the presence of IL1b. IL1b level
was found to be significantly lower in cRel knockdown
macrophages as compared with normal macrophages (Fig. 2A).
IL1b transcription on treatment with PGN for 2 hours was also
observed to be significantly inhibited in cRel knockdown
macrophages (Fig. 2D).
To check the involvement of MAPKs in PGN mediated
expression of IL1b macrophages were pre-incubated with JNK
inhibitor SP600125 (20 mM) or ERK inhibitor PD98059 (50 mM)
or p38 inhibitor SB202190 (5 mM) for 30 minutes and then
stimulated with PGN for 2 and 12 hours. PGN mediated IL1b
expression was observed to be partially dependent on JNK.
Inhibition of ERK and p38 did not affect the expression of PGN
mediated IL1b (Fig. 2C, 2D). MAPK activation ultimately leads to
the activation of transcription factor AP1 which is a heterodimer of
phosphorylated form of cJun and cfos. PGN stimulation of
peritoneal macrophages caused phosphorylation of cJun. This
phosphorylation was inhibited in TLR2 knockdown macrophages
and macrophages pre-treated with TLR2 specific blocking
antibody (Fig. 2E).
These observations demonstrate that PGN mediated IL1b
expression is through TLR2 and is dependent on JNK and NF-kB
pathways in peritoneal macrophages.
MDP stimulation inhibits PGN mediated IL1b
transcription by down regulating NF-kB and AP1
activation
There are reports for [6] and against [7] MDP mediated down
regulation of TLR2 mediated Th1 responses in different systems.
To study the effect of any crosstalk between Nod2 and TLR2
signaling, macrophages were treated with MDP, PGN and MDP +
PGN. MDP + PGN treated macrophages were found to secrete
lesser IL1b (Fig. 3A), had lower IL1b transcripts (Fig. 3B) and had
lesser pre-IL1b level (Fig. 3C) when compared with PGN
stimulated macrophages. Nod2 knockdown macrophages when
stimulated with PGN were found to express more IL1b as
compared to normal PGN stimulated macrophages at transcrip-
tional as well as secreted level, while MDP mediated IL1b
transcription was found to be significantly less in Nod2 knockdown
macrophages as compared to normal macrophages (Fig. 3B). This
implies that MDP mediated IL1b transcription is through Nod2
and Nod2 is down-regulating PGN mediated IL1b expression.
As NF-kB and AP1 are involved in PGN mediated IL1b
expression, therefore, the effect of MDP on PGN mediated
activation of NF-kB and AP1 was investigated by EMSA. PGN
mediated NF-kB and AP1 activation was observed to be
significantly down-regulated when macrophages were co-incubat-
ed with MDP and PGN (Fig. 3D, 3E). AP1 activation by a
synthetic TLR2/1 specific ligand Pam3CSK4 was also observed to
be down-regulated by MDP co-stimulation (Fig. 3E). This shows
that the modulatory effects of MDP are receptor dependent and
ligand independent.
MDP mediated downregulation is specific for TLR2/1
ligands
To check whether MDP mediated down regulating effects are
for all TLRs or they are restricted to TLR2 only, macrophages
were co-incubated with MDP and various TLR ligands or with
TLR ligands alone. Culture supernatants were collected after 12
hours and analysed for the presence of IL1b by ELISA (Fig. 4A). It
was observed that MDP mediated down-regulation of IL1b
expression was restricted to PGN and Pam3CSK4 (TLR2/1
ligands) only. LPS (TLR4 ligand) and zymosan A (TLR2/6 ligand
[18]) mediated IL1b expression was not affected by MDP co-
stimulation. Similar effects were observed at transcriptional level
(Fig. 4B).
To investigate whether MDP exerts its TLR2/1 ligand specific
down-regulating effects by lowering NF-kB activation, macro-
phages were stimulated with PGN or MDP + PGN, LPS (1 mg/ml)
or MDP + LPS, Pam3CSK4 (5 mg/ml) or MDP + Pam3CSK4,
zymosan A (5 mg/ml) or MDP + zymosan A for 40 minutes.
Down-regulation in nuclear cRel level (Fig. 4c, 4D) and NF-kB
activation (Fig. 4E) was observed in macrophages stimulated with
MDP + PGN/Pam3CSK4 compared to PGN/Pam3CSK4 alone
treated macrophages while MDP co-stimulation had no effect on
LPS and zymosan A mediated cRel nuclear translocation or NF-
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MDP are specific for TLR2/1 receptor.
MDP co-stimulation facilitate export of nuclear cRel
subunits in PGN stimulated macrophages
Lower level of nuclear cRel in MDP + PGN co-stimulated
macrophages can be because of either reduced nuclear import
(reduced phosphorylation of IkB) or enhanced nuclear export of
cRel subunits.
De novo synthesis of IkB is negative feedback mechanism for
regulation of NF-kB activity. NF-kB stimulating signals usually
also lead to synthesis of IkB which has nuclear localization signal.
In nucleus it binds to free cRel/p65 and transports them back to
cytosol. This ensures transient activation of NF-kB in response to
various stimuli [19]. To investigate whether downregulated
expression of cRel in nucleus is due to lower nuclear translocation
or enhanced transporting back of cRel, macrophages were treated
with eukaryotic protein synthesis inhibitor cycloheximide for 20
Figure 2. PGN mediated IL1b production is through TLR2 and involves NF-kB and JNK pathways. (A-E), Blocking antibody (1 mg/ml) was
added 20 minutes prior to stimulation, transfection with gene specific siRNA or scrambled sequence siRNA was done for 72 hours. MAPK inhibitors,
SP600125 (20 mM) or PD98059 (50 mM) or SB202190 (5 mM) were added 20 minutes prior to stimulation (A) Normal macrophages or TLR2 knockdown
macrophages or cRel knockdown macrophages or macrophages pre-treated with TLR2 specific blocking antibody were treated as indicated. After 12
hours culture supernatant was collected and the level of secreted IL1b was measured by ELISA. Each well contained 1610
6 macrophages. Statistical
significance was checked by one way ANOVA. P value was found to be significant (,0.0001). (B) Real time RT-PCR analysis of IL1b mRNA. Normal
macrophages or TLR2 knockdown macrophages or macrophages pre-treated with TLR2 specific blocking antibody were treated as indicated. Total
RNA was isolated after 2 hours and used for checking IL1b transcripts. Each bar represents fold expression relative to untreated macrophages.
Statistical significance was checked by one way ANOVA. P value was found to be significant (,0.0001). (C) Macrophages were left untreated or pre-
treated MAPK inhibitors (JNK inhibitor SP600125 (20 mM) or ERK inhibitor PD98059 (50 mM) or p38 inhibitor SB202190 (5 mM)) for 30 minutes and
then stimulated with MDP or PGN as indicated. Culture supernatants were collected after 12 hours and checked for the presence of secreted IL1b
using ELISA. Each well contained 1610
6 macrophages. Statistical significance was checked by one way ANOVA. P value was found to be significant
(,0.0001). (D) Real time RT-PCR analysis of IL1b mRNA. Macrophages were pre-treated with inhibitors or left untreated as described and stimulated
with PGN or left unstimulated and checked for the presence of IL1b transcripts after 2 hours of stimulation. Each bar represents fold expression
relative to untreated macrophages. Statistical significance was checked by one way ANOVA. P value was found to be significant (,0.0001). (E)
Western blot analysis of phospho-cJun. TLR2 knockdown macrophages or Nod2 knockdown macrophages or macrophages pre-treated with TLR2
specific blocking antibody were stimulated as indicated. Cell extracts were collected after 40 minutes of stimulation and checked for the presence of
phosphorylated form of cJun. Results in graph are presented as the mean of triplicate wells 6 SD. Blots correspond to one representative experiment
of three independent experiments.
doi:10.1371/journal.pone.0027828.g002
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for the presence of cRel in the nuclear extracts. It was observed
that cycloheximide pre-treatment abrogates the capacity of MDP
to down-regulate PGN mediated nuclear cRel level (Fig. 5A) and
NF-kB activity as checked by EMSA (Fig. 5C). This suggests that
MDP mediated signaling is not interfering with pathways that lead
Figure 3. MDP stimulation downregulates PGN mediated IL1b transcription by downregulating NF-kB and AP1 activation. (A-E), (A)
Normal or Nod2 knockdown macrophages were treated as indicated. Culture supernatants were collected after 12 hours and the level of secreted
IL1b was measured by ELISA. Each well contained 1610
6 macrophages. Statistical significance was checked by one way ANOVA. P value was found to
be significant (,0.0001). (B) Real time RT-PCR analysis of IL1b mRNA. Normal or Nod2 knockdown Macrophages were treated as indicated. Total RNA
was isolated used for checking IL1b transcripts. Each bar represents fold expression relative to untreated macrophages. Statistical significance was
checked by one way ANOVA. P value was found to be significant (,0.0001). (C) Western blot analysis of pre-IL1b. Peritoneal macrophages were
treated as indicated. Cell extracts were collected after 4 hours and analysed for the presence of pre-IL1b. ATP stimulation (1 mM) was given for 20
minutes after primary stimulation (MDP or PGN) was over. Lane1: untreated macrophages (123); lane2: MDP treated macrophages (127); lane3: PGN
treated macrophages (140); lane4: ATP stimulated macrophages (124); lane5: MDP+PGN treated macrophages (132); lane6: Macrophages treated with
MDP followed by ATP stimulation (108). Values in brackets indicate average integrated density values of spot densitometric analysis using software
Alpha Imager (D) Electrophoretic mobility shift Assay for NF-kB. Normal or TLR2 knockdown macrophages or macrophages pre-treated (for 20
minutes) with TLR2 specific blocking antibody (1 mg/ml) were stimulated as indicated. Nuclear extracts were prepared and incubated with 100 fmol
of biotinylated NF-kB binding sequence. EMSA was performed as described. Lane1: untreated macrophages; lane2: MDP treated macrophages; lane3:
PGN treated macrophages; lane4: MDP+PGN treated macrophages; lane5: PGN treated TLR2 knockdown macrophages; lane6: Macrophages treated
with TLR2 blocking antibody for 20 min and then stimulated with PGN; lane7: Nuclear extract of PGN stimulated macrophages is incubated with
100 fmol biotinylated NF-kB binding DNA and 100 pmol of unlabelled NF-kB binding DNA. Macrophages were treated for 40 minutes. (E)
Electrophoretic mobility shift Assay for AP1. Macrophages were treated for 40 minutes as indicated. Nuclear extracts were prepared and EMSA was
performed as described. Lane1: untreated macrophages (25); lane2: MDP treated macrophages (45); lane3: PGN treated macrophages (106); lane4:
MDP+PGN treated macrophages (87); lane5: Pam3CSK4 treated macrophages (82); lane6: Pam3CSK4+MDP treated macrophages (69); lane7: Nuclear
extract of PGN stimulated macrophages is incubated with 100 fmol biotinylated NF-kB binding DNA and 100 pmol of unlabelled AP1 binding DNA
(12). Values in brackets indicate average integrated density values of spot densitometric analysis using software Alpha Imager. Western blot and
EMSA correspond to one representative experiment of three and two independent experiments respectively.
doi:10.1371/journal.pone.0027828.g003
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was no significant change in phosphorylation level of IkB in MDP
+ PGN stimulated macrophages as compared to PGN stimulated
macrophages (Fig. 5B). This effect of MDP co-stimulation was
found to be same in case of LPS induced IkB phosphorylation
(Fig. 5D).
To check whether MDP co-stimulation has any effect on PGN
mediated activation of MAPKs (p38, ERK and JNK), macro-
phages were treated with MDP or PGN or MDP + PGN for 30
minutes and checked for the presence of phosphorylated forms of
various MAPKs. PGN mediated activation of p38, ERK and JNK
was observed to be unaffected by MDP co-stimulation (Fig. 5E).
Figure 4. MDP mediated downregulation is specific for TLR2/1 ligands. (A-E), (A) ELISA for IL1b; macrophages were stimulated as indicated.
Culture supernatants were collected after 12 hours and checked for the presence of IL1b. Each well contained 1610
6 macrophages. Statistical
significance was checked by one way ANOVA. P value was found to be significant (,0.0001). (B) Real time RT-PCR analysis of IL1b mRNA:
Macrophages were stimulated as indicated for 2 hours. Total RNA was isolated and checked for the presence of IL1b transcripts. Statistical
significance was checked by one way ANOVA. P value was found to be significant (,0.0001). (C and D) Western blot analyses of nuclear
translocation of cRel subunit of NF-kB. Macrophages were stimulated for 40 minutes as indicated. Nuclear and cytosolic extracts were prepared and
run on 10% SDS-PAGE. 30 mg of nuclear protein was loaded in each well corresponding to nuclear fraction. (E) Electrophoretic mobility shift Assay for
NF-kB. Macrophages were stimulated for 40 minutes as indicated. Nuclear extracts were prepared and incubated with 100 fmol of biotinylated NF-kB
binding sequence. EMSA was performed as described. Lane1: untreated macrophages (43); lane2: MDP+Pam3CSK4 treated macrophages (59); lane3:
Pam3CSK4 treated macrophages (75); lane4: MDP+zymosan A treated macrophages (94); lane5: zymosan A treated macrophages (91); lane6:
MDP+LPS treated macrophages (83); lane7: LPS treated macrophages (87); lane8: Nuclear extract of Pam3CSK4 stimulated macrophages is incubated
with 100 fmol biotinylated NF-kB binding DNA and 100 pmol of unlabelled NF-kB binding DNA (43). Values in brackets indicate average integrated
density values of spot densitometric analysis using software Alpha Imager. Results in graph are presented as the mean of triplicate wells 6 SD.
Western blot and EMSA correspond to one representative experiment of three and two independent experiments respectively.
doi:10.1371/journal.pone.0027828.g004
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Nod2 and TLR signaling affects many immune functions in
mice as well as humans. There are reports of interaction of Nod2
signaling with TLR pathways and modulation of those pathways
in different ways [2]. But most of the observations are system
specific and not all of the functions of TLR2 are affected by Nod2
in the same way. Convincing molecular mechanisms at the early
stages of TLR2 and Nod2 interaction are largely unknown. Part of
the problem is because of the fact that Nod2 signaling appears to
be different in different Nod2 expression cell populations. We
found the presence of inflammasome activating agent (ATP)
mandatory for MDP to cause secretion of IL1b from peritoneal
macrophages (Fig. 3A, 3C) while in some cases Nod2 stimulus
alone was sufficient for the effect [12]. Different cell populations
also vary in their ability to activate various MAPK in response to
MDP [20,21].
Presented data shows that negative regulating effects of MDP
are restricted to TLR2/1 ligands only. MDP co-stimulation could
interfere with PGN and Pam3CSK4 mediated NF-kB activation,
while LPS and zymosan A mediated NF-kB activation remained
unaffected. As downstream signaling cascade molecules for NF-kB
and MAPK pathways are shared between various TLRs, TLR2/1
specific responses can only be possible when interaction between
the TLR2/1 and Nod2 signaling is upstream, may be at the start
of the TLR2/1 signaling. In that condition interaction should
either weaken or strengthen all TLR2/1 responses but it was
clearly not the case. To the contrary, it was observed that MDP
Figure 5. MDP co-stimulation facilitates export of nuclear cRel subunits in PGN stimulated macrophages. (A-E), (A) Nuclear
translocation of cRel. Normal or cycloheximide (5 mg/ml) pre-treated (20 minutes prior to PGN or MDP+PGN stimulus) macrophages were stimulated
for 40 minutes as indicated. Nuclear extracts were prepared and run on 10% SDS-PAGE. 30 mg of nuclear extract was loaded per well. Results
correspond to one representative experiment of three independent experiments. (B) Phosphorylation of IkB. Normal or cycloheximide (5 mg/ml) pre-
treated (20 minutes prior to PGN or MDP+PGN stimulus) macrophages were stimulated for 30 minutes as indicated. Whole cell lysates were checked
for the presence of phosphorylated form of IkB. Results correspond to one representative experiment of three independent experiments. (C)
Electrophoretic mobility shift Assay for NF-kB. Macrophages were stimulated for 40 minutes as indicated. Nuclear extracts were prepared and
incubated with 100 fmol of biotinylated NF-kB binding sequence. EMSA was performed as described. Cycloheximide treatment was for 20 minutes
prior to PGN or MDP+PGN stimulation. Results correspond to one representative experiment of two independent experiments. (D) Phosphorylation
of IkB. Macrophages were stimulated for 30 minutes as indicated. Whole cell lysates were checked for the presence of phosphorylated form of IkB.
Results correspond to one representative experiment of three independent experiments (E) Activation of MAPKs. Macrophages were stimulated as
indicated for 30 minutes. Cell extracts were analysed for the presence of phosphorylated (activated) forms of p38, ERK and JNK. Results shown
correspond to one representative experiment of three independent experiments.
doi:10.1371/journal.pone.0027828.g005
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RANTES secretion, while it positively regulates IL10, TNFa,
iNOS and COX2 expression (Fig. 6A, 6B). This observation
suggests that it is not the universal cytokine expression which is
being affected, but it is IL1b (one particular cytokine) expression
induced by one particular receptor among many similar types
which is being affected. Our results are therefore, different from
those obtained by others investigators using splenocytes where
authors showed downregulation in cytokine expression induced by
PGN as well as LPS [6]. This again shows the cell type specific
modulation of TLR activity by Nod2.
Similar levels of cRel/NF-kB activity in nucleus of cyclohex-
imide treated MDP + PGN stimulated macrophages and PGN
stimulated macrophages suggests that MDP co-stimulation does
not interfere with nuclear import of cRel (Fig. 5A, 5C). Nod2
stimulation was also not found to affect PGN mediated MAPK
activation (Fig. 5E). These observations demonstrate that the
Nod2 and TLR2/1 pathways may not be interacting at the level of
activation of NF-kB and MAPKs. The down-regulating effects
observed may be due to the enhanced transporting back of cRel
from nucleus to the cytosol in MDP + PGN stimulated
macrophages compared to PGN alone stimulated macrophages.
A plausible explanation is that there is more unbound NF-kBi n
the nucleus of MDP + PGN stimulated macrophages which are
transported back to the cytosol by the newly synthesized IkB
subunits.
There are reports of auto activation of Nod2 in systems where it
is over expressed [22,23]. HEK293 cells when transfected with
Nod2 expressing plasmid show NF-kB activity even in absence of
any stimulus. Nod2 is a molecule that is supposed to be activated
by self oligomerization [24,25] and it is likely that enhanced
expression may promote self oligomerization even in absence of
ligand. Given the nature of the protein, it is likely that a fraction of
the total pool of the protein may be in activated state even in
normal physiological concentrations of protein. Here, we propose
that macrophages have basal Nod2 activity under unstimulated
conditions (i.e. in absence of PAMPs). This activity results in
activation of few transcription factors (TFs) with some of them
having overlapping binding sites with TFs activated by TLR2/1
signaling. Since each TLR activates a different profile of TFs (as
evident by different sets/levels of proteins induced by activation of
different TLRs) this mechanism explains for specific regulation of
a particular TLR without interfering with its immediate
downstream signaling. It assumes that Nod2 do not actually
interfere with TLR2/1 signaling, it only affects the activation/
function of those few TFs that share a part of binding sequence
with the TFs activated by Nod2 or that physically interact with
each other at promoter/enhancer elements (Fig. 7). By doing this
all the TLR2/1 processes remain intact except a few. As gene
expression is dictated by group of activated TFs and profile of
activated TFs varies for a given stimulus in different cell types
involved, this mechanism can also result in Nod2 dependent
positive regulation of some of the processes mediated by TLR2/1
or other TLRs.
This model assumes that Nod2 and TLR2 signaling pathways
controlling the expression of IL1b are distinct. They interact only
at the level of TF binding to the target sequences. Negative
regulation of IL1b is probably a special case. In fact we get positive
regulation of iNOS and COX2 genes after MDP co-stimulation as
compared to PGN stimulation. Surprisingly, similar signaling
pathways are involved in PGN mediated expression of iNOS and
COX2 as in the production of IL1b [9]. Our propositions
regarding system/receptor specific modulating effects of Nod2 are
supported by recent report, which showed synergistic effects of
Figure 6. Differential modulation of PGN mediated gene expression by MDP co-stimulation. (A) ELISA for IL10, TNFa and RANTES.
Normal of Nod2 knockout or scrambled sequence siRNA treated macrophages were stimulated for 12 hours with various ligands as indicated. Culture
supernatant was checked for the presence of indicated cytokines. Results are presented as the mean of triplicate wells 6 SD. Data is plotted on split
semi-log graph. Statistical significance was checked by two way ANOVA. P value was found to be significant (,0.0001). (B) Western blot analysis of
iNOS and COX2. Macrophages were stimulated for 6 hours as indicated and whole cell lysates were checked for the presence of iNOS and COX2
proteins. Results correspond to one representative experiment of three independent experiments.
doi:10.1371/journal.pone.0027828.g006
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RAW264.7 cells [26]. However, they also observed ligand
independent functions of over-expressed Nod2 which seems to
be its universal (system independent) property.
This mechanism indicates that the interaction of Nod2 and
TLRs is complex and relevant only at the system level where Nod2
affects and gets affected by different physiological states. It will be
premature to target Nod2 for any therapeutic approaches unless
that complex interrelation is better understood.
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